Primary study · included by 2 reviews

Souza 2014

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

The Effectiveness of Physical Adjunctive Interventions in the Acceleration of Orthodontic Tooth Movement: An Umbrella Review and Meta-Analysis.

Non-Cochrane · intervention · 2026 · cited as Souza 2014 · References 36-111; Supporting Information Tables S4-S6

Outcome this study informs	Pooled effect	Evidence	Certainty
Monthly upper canine retraction (mm) Low-level laser therapy (LLLT) vs Standard orthodontic treatment without the adjunctive intervention · Month 2	MD 0.27 [0.08, 0.46]	6 studies · 150 participants	Moderate
Monthly upper canine retraction (mm) Low-level laser therapy (LLLT) vs Standard orthodontic treatment without the adjunctive intervention · Month 3	MD 0.12 [-0.13, 0.37]	4 studies · 90 participants	Low
Monthly lower canine retraction (mm) Low-level laser therapy (LLLT) vs Standard orthodontic treatment without the adjunctive intervention · Month 2	MD -0.14 [-0.8, 0.51]	2 studies · 44 participants	Low
Monthly lower canine retraction (mm) Low-level laser therapy (LLLT) vs Standard orthodontic treatment without the adjunctive intervention · Month 3	MD -0.06 [-0.74, 0.61]	2 studies · 44 participants	Low
Cumulative upper canine retraction from baseline (mm) Low-level laser therapy (LLLT) vs Standard orthodontic treatment without the adjunctive intervention · Month 1	MD 0.31 [0.13, 0.49]	14 studies · 354 participants	Low
Monthly lower canine retraction (mm) Low-level laser therapy (LLLT) vs Standard orthodontic treatment without the adjunctive intervention · Month 1	MD 1.03 [0.67, 1.4]	2 studies · 44 participants	Low

Global Prevalence of Oral Potentially Malignant Disorders: An Updated Systematic Review and Meta-Analysis.

Non-Cochrane · prognostic · 2026 · cited as Souza 2014 · Appendix S5; Appendix S3

Outcome this study informs	Pooled effect	Evidence	Certainty
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 4.42 [2.33, 7.13]	22 studies · 308623 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 4.04 [2.07, 6.62]	21 studies · 308483 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.21 [3.56, 7.13]	36 studies · 298852 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 3.17 [1.64, 5.16]	3 studies · 9791 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.44 [3.37, 7.96]	35 studies · 3993638 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 3.86 [1.49, 7.24]	5 studies · 64762 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 1.22 [0.12, 3.30]	3 studies · 95589 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 4.89 [2.85, 7.42]	15 studies · 80908 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 1.55 [0.50, 3.12]	5 studies · 26549 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.99 [1.26, 13.89]	2 studies · 4660 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.40 [0.00, 23.55]	2 studies · 17905 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 3.52 [1.74, 5.86]	19 studies · 4376769 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 6.66 [0.00, 29.80]	2 studies · 4216 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 1.70 [0.73, 3.02]	7 studies · 27399 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.09 [3.62, 6.79]	38 studies · 348298 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 4.87 [3.20, 6.85]	22 studies · 100278 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 6.85 [0.67, 18.73]	3 studies · 22416 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 2.23 [0.29, 5.64]	2 studies · 850 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.92 [3.17, 9.43]	24 studies · 262206 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 0.72 [0.00, 3.76]	4 studies · 4407817 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 4.67 [3.62, 5.84]	96 studies · 8808614 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 0.72 [0.00, 3.76]	4 studies · 4407817 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.26 [0.18, 16.59]	3 studies · 3599486 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.38 [4.12, 6.78]	86 studies · 8717062 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 4.85 [3.65, 6.21]	75 studies · 8500131 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 3.74 [2.03, 5.92]	25 studies · 3991311 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 14.01 [0.18, 42.14]	3 studies · 5842 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 6.82 [1.00, 17.19]	2 studies · 17423 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 7.31 [3.09, 13.06]	15 studies · 92236 participants	GRADE not reported
Prevalence of OPMD (any histopathologically confirmed OPMD)	Prevalence (%) 5.17 [4.07, 6.40]	108 studies · 9025685 participants	GRADE not reported

Also linked to PM42046528-P1-O4, which does not match a current question in this review.

2 including reviews in total.